27 Sep 2004
Marcy l'Etoile, France - September 27th, 2004. A major player in the field of in vitro diagnostics, bioMérieux confirms its constant commitment to the fight against AIDS with the launch of two new adv...
23 Jul 2004
VIDAS® D-Dimer Exclusion™ test from bioMérieux for reliable exclusion of pulmonary embolism and deep vein thrombosis
Marcy l'Etoile, France - July 23rd, 2004. bioMérieux announces that its D-dimer assay, VIDAS D-Dimer Exclusion, is now cleared by the U.S. Food and Drug Administration (FDA) to exclude both pulmonary ...
21 Jul 2004
Marcy l'Etoile, France - July 21st, 2004. bioMérieux (Euronext : FR0010096479 – BIM) today announced: During the first six months to June 2004, bioMérieux achieved sales of Euros 461 million - an incr...
13 May 2004
Marcy l'Etoile, France - May 13, 2004. Eppendorf AG, Germany, and bioMérieux, France, have concluded a non-exclusive licensing agreement for Eppendorf products using bioMérieux's exclusively controlle...
06 May 2004
Marcy l'Etoile, France - May 6th, 2004. bioMérieux announces that following prospective management studies on its VIDAS D-Dimer test resulting in FDA approval and CE marking, the VIDAS D-Dimer New tes...
04 May 2004
Marcy l'Etoile, France - May 4th, 2004. A major player in the field of infectious disease, bioMérieux, and its exclusive distributor for South Africa, Omnimed, have just won a most important tender fo...
20 Apr 2004
Marcy l'Etoile, France - 20 avril 2004. The European Patent Office’s Board of Appeal has found in favour of bioMérieux in the opposition to its European patent for the Boom technology. European Patent...
02 Apr 2004
NucliSens®, miniMAG™, the first product from bioMérieux’s next generation nucleic acid extraction platform now available.
Marcy l'Etoile, France - April 2nd, 2004. bioMérieux announces the introduction of NucliSens miniMAG and NucliSens Magnetic Extraction Reagents, two key components of the company’s next generation nuc...
26 Mar 2004
Marcy-l’Etoile, France - March 26, 2004. bioMérieux announces U.S. FDA-CBER (1) Premarket Notification 510(k) clearance of the recently launched, innovative polycarbonate BacT/ALERT BPA and BacT/ALERT...
24 Feb 2004
bioMérieux launches its first molecular multi-detection test for food and feed analysis : FoodExpert-ID®
Marcy l'Etoile, France - February 24th, 2004. bioMérieux announces the launch of FoodExpert-ID, the first high-density DNA chip for food and animal feed testing. The FoodExpert-ID test, powered by Aff...
14 Jan 2004
Marcy l'Etoile, France - January 14th, 2004. bioMerieux, is a major player in the field of in vitro infectious disease diagnostics. Founded in 1963 in France, the company designs, develops, manufactur...
08 Jan 2004
Marcy l'Etoile, France - January 8th, 2004. bioMérieux has received CE Mark certifications for all of its in vitro diagnostic (IVD) products currently marketed in the European Union (EU). In complianc...
06 Jan 2004
Cepheid (NASDAQ: CPHD) today announced that it has entered into a strategic commercial relationship with bioMerieux for bioMerieux to develop DNA testing products embodying its proprietary NASBA (Nucl...